1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMaintenance of Project ACCESS: Increasing Access to Cervical Cancer Screening & Treatment Services in Texas is sponsored by Cancer Prevention and Research Institute of Texas (CPRIT). This opportunity supports mission-aligned projects and measurable outcomes.
Get alerted about grants like this
Save a search for “Cancer Prevention and Research Institute of Texas (CPRIT)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
# Cancer Prevention and Research Institute of Texas [](https://twitter. com/CPRITTexas "Twitter") [](https://www. facebook.
com/pages/CPRITTexas/102553776486201 "Facebook") [](https://www. youtube. com/cprittexas "YouTube") [](https://www.
linkedin. com/company/cancer-prevention-and-research-institute-of-texas "LinkedIn") Grants FundedGrantee ResourcesCPRIT Scholars Awarded On August 17, 2022 Title Project ACCESS: Increasing Access to Cervical Cancer Screening & Treatment Services in Texas Award Mechanism Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations Institution/Organization The University of Texas M. D.
Anderson Cancer Center Principal Investigator/Program Director Melissa Varon Contracted Amount$2498445 Lay Summary Need: In the US, cervical cancer incidence and mortality rates have decreased by 70% due to implementation of screening programs based on Pap and human papillomavirus (HPV) testing.
However, women living in medically underserved areas (MUAs) still experience significant health disparities including a higher burden of cervical cancer. Texas has one of the highest rates of cervical cancer incidence and mortality in the US and women in MUAs are less likely to receive cervical cancer screening and appropriate follow up.
Overall Project Strategy: We propose a Maintenance Expansion of our current CPRIT-funded project (PP190014), which is an Initial Expansion of PP150012. We will continue to off... Need: In the US, cervical cancer incidence and mortality rates have decreased by 70% due to implementation of screening programs based on Pap and human papillomavirus (HPV) testing.
However, women living in medically underserved areas (MUAs) still experience significant health disparities including a higher burden of cervical cancer. Texas has one of the highest rates of cervical cancer incidence and mortality in the US and women in MUAs are less likely to receive cervical cancer screening and appropriate follow up.
Overall Project Strategy: We propose a Maintenance Expansion of our current CPRIT-funded project (PP190014), which is an Initial Expansion of PP150012. We will continue to offer cervical cancer prevention services to women at our existing 10 collaborating sites in the Rio Grande Valley (RGV), Laredo, Northeast Texas, Bastrop and Alvin, and include new sites in Corpus Christi, Waxahachie and Pasadena.
We propose to continue our comprehensive approach which includes public education about screening and HPV vaccination through community outreach and clinic in-reach, coupled with patient navigation to services. We will also provide education and training to local providers to build capacity to deliver quality cervical cancer prevention services through hands-on colposcopy and LEEP training courses and telementoring using Project ECHO.
Specific Goals: Goal 1: Increase cervical cancer screening rates in MUAs through clinic inreach and community outreach educational programs coupled with patient navigation services. Objective 1: Increase the number of women undergoing cervical cancer screening with Pap and/or HPV testing at participating sites by 30% from a baseline of 13,122 to 17,059 women per year, for a total of 51,177 women over the 3-year project period.
Objective 2: Expand the number of partnering sites providing inreach education on cervical cancer screening and HPV vaccination from a baseline of 10 to 13 (23% increase). Objective 3: Educate 15,000 women (5,000 per year) in participating regions on cervical cancer screening through the implementation of Salud en Mis Manos (SEMM), an evidence-based community outreach educational program to increase cervical cancer screening.
Eligible women will be navigated to participating clinics for screening. Goal 2: Increase local capacity to deliver evidence-based cervical cancer prevention services through professional education, training and support of local providers in MUAs.
Objective 1: Increase the number of local providers managing abnormal cervical cancer screening tests including independently performing colposcopy, cervical biopsies and/or LEEP at participating sites by 30% over the three-year project period (from a baseline of 20 to 26 providers). Objective 2: Expand the Project ECHO telementoring program from a baseline of 10 to 13 participating sites (23% increase).
Objective 3: Provide 6 hands-on and/or virtual/blended training courses (two per year) to teach colposcopy, cervical biopsy and LEEP to medical providers from partner sites (25 participants per course). Goal 3: Improve coordination of cervical cancer prevention efforts through community events that combine cervical cancer screening and HPV vaccination for women and their family members.
Objective 1: Hold 6 one-day events (two per year) that offer both cervical cancer screening and HPV vaccination services for women and their family members. These events will be rotated among participating clinics and performed in collaboration with the Area Health Education Center (AHEC).
We will screen 20 women and vaccinate 50 eligible individuals per event, for a total of 120 women screened and 300 individuals vaccinated over the three-year project period. We estimate that we will provide 113,816 services and that the overall project will result in 96,552 unique people served (32,184 individuals per year). This includes 51,177 women undergoing cervical cancer screening.
We estimate that we will reach 90,000 individuals through outreach activities, flyer distributions, publications and/or public service announcements. Significance and Impact: We expect to demonstrate that a comprehensive approach of public education and patient navigation will increase cervical cancer screening rates. Professional education, training and mentoring will increase local capacity to manage women with abnormal test results.
We anticipate that these interventions will result in increased rates of detection and treatment of women with preinvasive cervical disease, ultimately decreasing cervical cancer incidence and mortality. This program is designed to be sustainable through building local cadres of providers able to train and mentor others.
If successful, our intervention can be adapted and disseminated across Texas, the US, and globally to improve cervical cancer prevention efforts. Grants FundedCPRIT ScholarsGrantee Resources * Frequently Asked Questions * CEO Cancer Gold Standard * Texas Homeland Security 1701 North Congress Avenue, Suite 6-127 Purchase your Texans Conquer Cancer License Plate
Based on current listing details, eligibility includes: Universities and research institutions in Texas. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $2,450,000 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Individual Investigator Research Awards for Clinical Trials (IIRACT) is a grant from the Cancer Prevention and Research Institute of Texas (CPRIT) that funds clinical trials research aimed at preventing and curing cancer in Texas. The program supports Texas-based entities conducting clinical trials across cancer types, with applications accepted through May 20, 2026 (RRCTA mechanism) and with an April 28, 2026 deadline for individual investigator awards. Eligible applicants include nonprofit institutions and private companies based in Texas. CPRIT now supports ORCID IDs in applicant profiles to streamline the application process.
CPRIT Seed Company Award (RFA C-26.1-SEED) is a grant from the Cancer Prevention and Research Institute of Texas (CPRIT) that funds early-stage Texas-based companies developing cancer prevention or research products. The Seed Award supports product development research — including therapeutics, diagnostics, and new technologies — for companies at the pre-commercialization stage looking to advance their cancer-related innovations toward market readiness. CPRIT's product development grants are designed to catalyze commercial investment and keep cancer-focused companies growing within Texas. Eligible applicants are Texas-based for-profit companies, or companies willing to relocate to Texas. Awards are available up to ,000,000. The deadline for preliminary applications is April 16, 2026, with full applications due June 10, 2026.